Next Generation Cancer Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Technology (QPCR and Multiplexing, Benchtop Sequencers, Lab-on-a-chip, Next Generation Sequencing, Protein Microarrays, DNA Microarrays); Application (Biomarker Development, Proteomic Analysis, CTC Analysis, Genetic Analysis, Epigenetic Analysis); Cancer Type (Lung Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, Others); Function (Cancer Screening, Therapeutic Monitoring, Prognosis Diagnostics, Risk Analysis, Companion Diagnostics) and Geography
Report Code: TIPRE00006920 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
MARKET OVERVIEW
Next-generation cancer diagnostics are helping in the early detection and prevention of cancer. Researchers are constantly working on developing novel cancer diagnostic tools as well as improving existing ones. Many market companies are working together to create new cancer biomarkers and assays, which is fueling market growth. Cancer diagnostics assist in early detection of cancers for better treatment options. Next generation cancer diagnostics will assist in detection of disease with full precision and at lower costs.
MARKET SCOPE
The "Global Next Generation Cancer Diagnostics Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the next generation cancer diagnostics market with detailed market segmentation by technology, application, cancer type and function. The report provides key statistics on the market status of the leading next generation cancer diagnostics market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
MARKET DYNAMICS
Drivers:
Restraints:
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The next generation cancer diagnostics market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the next generation cancer diagnostics market in these regions.
IMPACT OF COVID-19 ON NEXT GENERATION CANCER DIAGNOSTICS MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.
The report covers key developments in the next generation cancer diagnostics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from next generation cancer diagnostics market are anticipated to lucrative growth opportunities in the future with the rising demand for next generation cancer diagnostics in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the next generation cancer diagnostics market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
Next-generation cancer diagnostics are helping in the early detection and prevention of cancer. Researchers are constantly working on developing novel cancer diagnostic tools as well as improving existing ones. Many market companies are working together to create new cancer biomarkers and assays, which is fueling market growth. Cancer diagnostics assist in early detection of cancers for better treatment options. Next generation cancer diagnostics will assist in detection of disease with full precision and at lower costs.
MARKET SCOPE
The "Global Next Generation Cancer Diagnostics Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the next generation cancer diagnostics market with detailed market segmentation by technology, application, cancer type and function. The report provides key statistics on the market status of the leading next generation cancer diagnostics market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
- Based on technology the market is segmented as, qPCR and multiplexing, benchtop sequencers, lab-on-a-chip, next generation sequencing, protein microarrays, DNA microarrays.
- Based on application the market is segmented as, biomarker development, proteomic analysis, CTC analysis, genetic analysis, and epigenetic analysis.
- Based on cancer type the market is segmented as, lung cancer, colorectal cancer, breast cancer, prostate cancer, and others.
- Based on function the market is segmented as, cancer screening, therapeutic monitoring, prognosis diagnostics, risk analysis, and companion diagnostics.
MARKET DYNAMICS
Drivers:
- Rising prevalences of cancers and different kind of malignancies.
- Growing awareness among people for early detection of disease is also expected to spur the market growth.
- Extensive R&D efforts to develop more advanced and precise diagnostics for cancer is likely to fuel the market growth.
- Rising automation and next level technologies in diagnostic laboratories.
Restraints:
- However, involvement of high cost in diagnostic imaging systems and stringent regulatory framework are likely to restrain market growth during the forecast period.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The next generation cancer diagnostics market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the next generation cancer diagnostics market in these regions.
IMPACT OF COVID-19 ON NEXT GENERATION CANCER DIAGNOSTICS MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.
The report covers key developments in the next generation cancer diagnostics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from next generation cancer diagnostics market are anticipated to lucrative growth opportunities in the future with the rising demand for next generation cancer diagnostics in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the next generation cancer diagnostics market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- Agilent Technologies, Inc
- Illumina, Inc
- PerkinElmer Inc
- F. Hoffmann-La Roche Ltd
- GENERAL ELECTRIC
- OPKO Health, Inc.
- QIAGEN
- Thermo Fisher Scientific Inc.
- Abbott
- Cepheid
The List of Companies
- Agilent Technologies, Inc
- Illumina, Inc
- PerkinElmer Inc
- F. Hoffmann-La Roche Ltd
- GENERAL ELECTRIC
- OPKO Health, Inc.
- QIAGEN
- Thermo Fisher Scientific Inc.
- Abbott
- Cepheid
- Novartis AG
- Myriad Genetics, Inc
- Genomic Testing Cooperative
- Almac Group
- Sysmex Corporation
- Agilent Technologies, Inc
- Illumina, Inc
- PerkinElmer Inc
- F. Hoffmann-La Roche Ltd
- GENERAL ELECTRIC
- OPKO Health, Inc.
- QIAGEN
- Thermo Fisher Scientific Inc.
- Abbott
- Cepheid
- Novartis AG
- Myriad Genetics, Inc
- Genomic Testing Cooperative
- Almac Group
- Sysmex Corporation
Get the Latest COVID-19 Analysis on this market
Have a Question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Pricing
-
$3000
-
$4550
-
$6550
-
$8550
-
Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.
Inquire for Discount